Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00688935 · ClinicalTrials.gov registry record · NA
Young Blind Child Melatonin Treatment Study
A NA study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00688935 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 9 participants.
The verdict
NCT00688935, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.
Interventions
- BIOLOGICAL Melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2005-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00688935
The ClinicalTrials.gov registry entry for NCT00688935 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Melatonin is the first listed.
NCT00688935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00688935 about?
NCT00688935 is a clinical study titled "Young Blind Child Melatonin Treatment Study". The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.
What is the current status of trial NCT00688935?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2005-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT00688935?
The interventions under investigation include: Melatonin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00688935?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.